C16 Biosciences
C16 Biosciences, based in New York, develops sustainable alternatives to oils and fats using a biomanufacturing process, with products like Palmless™ and Torula oil.
Company History
C16 Biosciences, based in New York, NY, USA, is a growing player in the healthcare sector, specifically within the industrial bio sub-industry. Founded in 2018 as part of the S18 Y-Combinator batch, the company has developed proprietary biodesigned performance ingredients favorable to sustainability. Notably, it has successfully obtained significant funding, including a $3.5 million grant from the Bill & Melinda Gates Foundation and a $1 million investment from Elemental Excelerator, enhancing its operational capabilities and reach.
Key Products
C16 Biosciences' product lineup primarily includes sustainable alternatives to traditional oils and fats. A standout product is Palmless™ alternative fats and oils, which provide a sustainable substitute for palm oil. Another significant product is the luxury bio-based Torula oil, which is clinically proven to promote healthier skin and hair. Launched in 2023, Torula oil featured in two award-winning product launches that sold out in less than 24 hours.
Innovative Manufacturing Processes
C16 Biosciences employs a unique biomanufacturing process that leverages yeast fermentation to produce oils and fats, supporting a circular economy model. This innovative approach allows the production of these substances without relying on arable land, thus addressing environmental concerns associated with traditional oil production methods. This process is emblematic of the company’s commitment to sustainability and environmental stewardship.
Awards and Recognition
C16 Biosciences has been recognized for its pioneering work in the field of biosciences. Notably, the company received the World Cell-base Innovation Award for the 'Best Cell-based Ingredient' and was selected for Elemental Excelerator’s Cohort 12 in 2023. These accolades affirm the company's leading role in developing sustainable biodesigned ingredients and its innovative approach to industrial biotechnology.
Future Plans
Looking ahead, C16 Biosciences aims to expand its research and development capabilities, supported by recent funding from the Bill & Melinda Gates Foundation. The company plans to hire additional R&D staff to bolster its efforts in developing new sustainable ingredients, particularly in the food category. These initiatives will likely facilitate the company's ongoing contributions to sustainable industrial biotechnology.